(Q35951868)

11 August 2017

1 reference

title

Fibrosing alveolitis in systemic sclerosis: the need for early screening and treatment (English)

1 reference

11 August 2017

Sahhar J

1

1 reference

11 August 2017

Littlejohn G

series ordinal

2

1 reference

11 August 2017

Conron M

series ordinal

3

1 reference

11 August 2017

language of work or name

1 reference

1 November 2004

1 reference

Internal Medicine Journal

11 August 2017

1 reference

11 August 2017

34

1 reference

11 August 2017

11

1 reference

11 August 2017

626-638

1 reference

Longitudinal changes in lung function and respiratory symptoms in progressive systemic sclerosis. Prospective study

11 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2004.00674.X

Predictors of end stage lung disease in a cohort of patients with scleroderma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2004.00674.X

Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2004.00674.X

The accuracy of the clinical diagnosis of new-onset idiopathic pulmonary fibrosis and other interstitial lung disease: A prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2004.00674.X

Elevated serum KL-6 levels in patients with systemic sclerosis: association with the severity of pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2004.00674.X

Steroids in idiopathic pulmonary fibrosis: a prospective assessment of adverse reactions, response to therapy, and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2004.00674.X

Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2004.00674.X

High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2004.00674.X

Diffuse interstitial pneumonitis. Clinicopathologic correlations in 20 patients treated with prednisone/azathioprine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2004.00674.X

The rapamycin analogue SDZ RAD attenuates bleomycin-induced pulmonary fibrosis in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2004.00674.X

Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2004.00674.X

Interstitial lung disease and gastroesophageal reflux.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2004.00674.X

10.1111/J.1445-5994.2004.00674.X

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference